J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 34 (1977), 537-540; DOI 10.1099/0022-1317-34-3-537
© 1977 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuwata, T.
Right arrow Articles by Morinaga, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuwata, T.
Right arrow Articles by Morinaga, N.
Agricola
Right arrow Articles by Kuwata, T.
Right arrow Articles by Morinaga, N.

Effects of Ouabain on the Anticellular and Antiviral Activities of Human and Mouse Interferon

T. Kuwata, A. Fuse and Naoko Morinaga

Department of Microbiology, School of Medicine, Chiba University, Chiba 280, Japan

When transformed human embryonic cells, RSa and RSb, were treated for 48 h with both 10-7 M-ouabain and 1000 units/ml of human leucocyte interferon, there was an additive suppression of cell growth. In contrast, the antiviral action of the human interferon was inhibited by this concentration of ouabain. Similar effects of combined treatment with interferon and ouabain were found with IFr cells (which are relatively resistant to the anticellular effect of interferon), and with mouse cells of the K3b line.

Received 17 May 1976; accepted 19 October 1976.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1977 by the Society for General Microbiology.